The 1st International Conference on Clinical and Scientific Advances in ME/CFS and Long COVID aims to raise awareness, clarify misconceptions, promote understanding, and stimulate discussion among healthcare professionals, investigators, policymakers, patients, and community representatives on the clinical manifestations, management, therapeutic options, and health challenges related to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID.

The incidence of ME/CFS continues to rise globally, in the aftermath of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and Long COVID, increasing the need for informed diagnosis and treatment. Emerging evidence reveals many shared underlying biological abnormalities and symptoms reported in both illnesses, documented by multiple laboratories. This underscores the importance of sustained medical education and regular updates on research, diagnostic, and treatment guidelines.

The program will feature state-of-the-art lectures, and interactive sessions designed to address the educational needs of Portuguese healthcare professionals and health system capacity. It offers dedicated time for discussions to enhance knowledge exchange and reinforce the implementation of guidelines and recommendations.

The conference will take place on April 3 and 4, 2024, in Lisbon, at the premises of FLAD – Luso-American Development Foundation. You can attend in person (places are limited) or participate online via streaming.